Atlas FDA

PRO-TRAC II TACROLIMUS ELISA KIT

FDA premarket approval P970025 · decided 1999-04-27

Approval details

PMA number
P970025
Trade name
PRO-TRAC II TACROLIMUS ELISA KIT
Generic name
ENZYME IMMUNOASSAY, TRACROLIMUS
Applicant
DiaSorin, Inc.
Date received
1997-06-30
Decision date
1999-04-27
Days to decision
666 days
Decision code
APRL
Product code
MLM
Advisory committee
Clinical Toxicology
Expedited review
No
Location
Stillwater, MN
Statement
Approval for PRO-Trac(TM) II Tacrolimus ELISA Kit. This device is indicated for the quantitative determination of tacrolimus ELISA Kit. This device indicated for the quantitative determination of tacrolimus (Prograf(R) FK506) and some metabolites in EDTA or heparinized human whole blood as an aid in the management of liver transplant patients receiving tacrolimus therapy.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX (K260770)DiaSorin, Inc.2026-06-04
LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261) (DEN250032)DiaSorin, Inc.2025-12-23
LIAISON VZV IgG HT, LIAISON Control VZV IgG HT (K231214)DiaSorin, Inc.2023-10-27
LIAISON Anti-HAV; LIAISON XS (K223403)DiaSorin, Inc.2022-12-09
LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus (K213858)DiaSorin, Inc.2022-07-26
LIAISON MeMed BV, LIAISON MeMed BV Control Set (K213936)DiaSorin, Inc.2022-07-14
LIAISON Ferritin (K193650)DiaSorin, Inc.2021-09-14
LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody Plus (K202573)DiaSorin, Inc.2021-02-18